PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15526248-6	2004	In the quinapril group, the mean maximal vasoconstriction to Ang II was similar between DD- and ID/II-genotype (59.6+/-9.19% [n=8] vs. 57.7+/-4.07% [n=35]; p=0.85).	Quinapril	7-16	angiotensinogen	Homo sapiens	61-67	
15353612-12	2005	In order to confirm that the action of quinapril occurred predominantly through suppression of angiotensin II, parallel experiments with the angiotensin receptor antagonist candesartan cilexetil demonstrated that this agent also inhibited disease activity in CIA.	Quinapril	39-48	angiotensinogen	Homo sapiens	95-109	
16206603-0	2005	[Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect of monotherapy (data from the trial SADKO-CHF)].	Quinapril	23-32	angiotensinogen	Homo sapiens	76-90	
17954368-2	2007	We evaluated whether quinapril unmasks angiotensin II-dependent sympathetic activity on amlodipine.	Quinapril	21-30	angiotensinogen	Homo sapiens	39-53	
15526248-7	2004	CONCLUSIONS: DD-genotype patients showed decreased vascular responses to Ang II but treatment with quinapril completely restored the decreased vascular response in DD-genotype patients to the same level as II/ID-genotype patients, while no effect of quinapril was demonstrated in the II/ID-genotype patients.	Quinapril	99-108	angiotensinogen	Homo sapiens	73-79	
11849656-6	2002	According to quinapril treatment, the AGT T homozygotes significantly showed a beneficial effect of quinapril on MLD (P=0.013) and late lumen loss (P=0.013).	Quinapril	13-22	angiotensinogen	Homo sapiens	38-41	
11849656-6	2002	According to quinapril treatment, the AGT T homozygotes significantly showed a beneficial effect of quinapril on MLD (P=0.013) and late lumen loss (P=0.013).	Quinapril	100-109	angiotensinogen	Homo sapiens	38-41	
11849656-9	2002	In conclusion, the AGT T homozygotes might benefit from effects of quinapril on preventing restenosis after PCI.	Quinapril	67-76	angiotensinogen	Homo sapiens	19-22	
1575171-6	1992	The blood pressure reduction in patients with mild hypertension receiving long-term quinapril therapy may be more closely related to prolonged angiotensin-converting enzyme inhibition or to an effect on tissue angiotensin II concentration than to the plasma half-life.	Quinapril	84-93	angiotensinogen	Homo sapiens	210-224	
9049577-3	1997	This study assesses the in vivo effect of single oral doses of quinapril and enalapril, in attenuating the vasoconstrictive action of angiotensin I (AI) (which we have previously shown depends on its conversion to angiotensin II (AII) by vascular ACE) in the forearm resistance vessels of man.	Quinapril	63-72	angiotensinogen	Homo sapiens	134-147	
9049577-3	1997	This study assesses the in vivo effect of single oral doses of quinapril and enalapril, in attenuating the vasoconstrictive action of angiotensin I (AI) (which we have previously shown depends on its conversion to angiotensin II (AII) by vascular ACE) in the forearm resistance vessels of man.	Quinapril	63-72	angiotensinogen	Homo sapiens	214-228	
9049577-3	1997	This study assesses the in vivo effect of single oral doses of quinapril and enalapril, in attenuating the vasoconstrictive action of angiotensin I (AI) (which we have previously shown depends on its conversion to angiotensin II (AII) by vascular ACE) in the forearm resistance vessels of man.	Quinapril	63-72	angiotensinogen	Homo sapiens	230-233	
9037848-3	1996	Because quinapril is an angiotensin-converting enzyme inhibitor and could result in a decrease of angiotensin-II, Quinapril was used to treat patients with mild or moderate hypertension in order to observe the change of plasma serotonin.	Quinapril	8-17	angiotensinogen	Homo sapiens	98-112	
2539762-4	1989	In addition, plasma renin activity increased and aldosterone and angiotensin II concentrations decreased following single or multiple doses of quinapril.	Quinapril	143-152	angiotensinogen	Homo sapiens	65-79